Search bioRxiv⌕ Search

Biology subjects

Vosough, F.

Publications and source records attributed to Vosough, F..

3 recordsLinked to original sources

Residue-level structural information from isotope-edited FTIR spectroscopy reveals distinct molecular structures of different amyloid-β42 oligomers

Oligomers of the amyloid-{beta} peptide 1-42 (A{beta}42) are one of the underlying causes of pathogenicity in Alzheimers disease. However, investigating their molecular structure is challenging with common structural biology techniques. In this work we employed isotope-edited Fourier transform infrared spectroscopy with site-specific labeling, an advanced method enabling collection of residue-level structural information on oligomers of all sizes in aqueous solution. The A{beta}42 peptides studied comprised those that were 13C, 15N-labeled at either residue V18, F20, A30, or I32, as well as those doubly-labeled at V18 and A30, at F20 and A30, and at F20 and I32. We studied three types of oligomers. For A{beta}42 oligomers prepared in the absence of detergents, all labeled residues are positioned within {beta}-strands. Moreover, in these oligomers intramolecular vibrational coupling was detected between residues V18 and A30, as well as F20 and A30, in addition to intermolecular coupling between V18 amides, and between F20 and I32 residues. This indicates that these residues are close in the 3-dimensional structure (contact). By contrast, detergent-stabilized oligomers formed in the presence of low concentrations of sodium dodecyl sulfate have different structures: V18 and F20 are not incorporated in a {beta}-sheet, whereas A30 and I32 are found to reside in a {beta}-sheet. No interactions (contacts) were detected between any pair of labeled residues in detergent-stabilized A{beta}42 oligomers. We propose that in our oligomer preparations, V18 and F20 are stably incorporated into a {beta}-sheet only for oligomers that are larger than dodecamers.

biophysics↗

Characterization of uranyl ion binding to amyloid beta (Aβ) peptides: effects on Aβ structure and aggregation

AbstractUranium (U) is naturally present in ambient air, water, and soil, and depleted uranium (DU) is released into the environment via industrial and military activities. While the radiological damage from U is rather well understood, less is known about the chemical damage mechanisms, which dominate in DU. Heavy metal exposure is associated with numerous health conditions including Alzheimers disease (AD), the most prevalent age-related cause of dementia. The pathological hallmark of AD is deposition of amyloid plaques, consisting mainly of amyloid-{beta} (A{beta}) peptides aggregated into amyloid fibrils in the brain. However, the toxic species in AD are likely oligomeric A{beta} aggregates. Exposure to heavy metals such as Cd, Hg, Mn, and Pb is known to increase A{beta} production, and these metals bind to A{beta} peptides and modulate their aggregation. Possible effects of U in AD pathology have been sparsely studied. Here, we use biophysical techniques to study in vitro interactions between A{beta} peptides and uranyl ions, UO22+, of DU. We show for the first time that uranyl ions bind to A{beta} peptides with affinities in the micromolar range, induce structural changes in A{beta} monomers and oligomers, and inhibit A{beta} fibrillization. General toxic mechanisms of uranyl ions could be modulation of protein folding, misfolding, and aggregation.

biophysics↗

Lithium ions display weak interaction with amyloid-beta (Aβ) peptides and have minor effects on their aggregation

Alzheimers disease (AD) is an incurable disease and the main cause of age-related dementia worldwide, despite decades of research. Treatment of AD with lithium (Li) has showed promising results, but the underlying mechanism is unclear. The pathological hallmark of AD brains is deposition of amyloid plaques, consisting mainly of amyloid-{beta} (A{beta}) peptides aggregated into amyloid fibrils. The plaques contain also metal ions of e.g. Cu, Fe, and Zn, and such ions are known to interact with A{beta} peptides and modulate their aggregation and toxicity. The interactions between A{beta} peptides and Li+ ions have however not been well investigated. Here, we use a range of biophysical techniques to characterize in vitro interactions between A{beta} peptides and Li+ ions. We show that Li+ ions display weak and non-specific interactions with A{beta} peptides, and have minor effects on A{beta} aggregation. These results indicate that possible beneficial effects of Li on AD pathology are not likely caused by direct interactions between A{beta} peptides and Li+ ions.

biochemistry↗